COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Aseptic Manufacturing Of Parenteral Drug Products

10 Dec 2020

In our latest white paper, the fill/finish experts at Piramal Pharma Solutions’ Lexington, Kentucky...

History, Ingenuity & Excellence: The Story Of ADC Development At Piramal Pharma Solutions

10 Oct 2020

Piramal Pharma Solutions (PPS) maintains its position as an international leader in the development...

The importance of Data Analysis in Solid-State Characterisation

25 Aug 2020

Performing solid-state characterization involves integrating a large amount of data and properly int...

Integrated Services: Partnerships For Success

31 Jul 2020

Efficiency, speed-to-market, and access to unique expertise are among the key benefits of partnering...

Patient Centricity: A compassionate Approach That Puts Patients At The Forefront Of Our Mission

18 Jun 2020

Embracing a patient-focused ideology represents a massive change for a CDMO. In our new white paper,...

Enhancing Bioavailability When Developing Oral Solid Formulations

06 Jun 2020

Poor bioavailability, often caused by low solubility, is a challenge facing many NCEs. In this paper...